MedTrace Logo

Blue Protocol and Eko Artificial Intelligence Are Best (BEA-BEST)

NCT05144633 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-01-20

No results posted yet for this study

Summary

This is an observational study that will be enrolling University of Louisville patients who present to the Emergency Department in Acute Respiratory Failure. This study will be to determine if the addition of Eko AI-assisted lung auscultation examination to a standard of care Pulmonary POCUS + assists with acute respiratory failure diagnosis.

Conditions

  • Acute Respiratory Failure

Interventions

DEVICE

Auscultation

This study will be to determine if the addition of Eko AI-assisted lung auscultation examination to a standard of care Pulmonary POCUS + assists with acute respiratory failure diagnosis.

Sponsors & Collaborators

  • Eko Devices, Inc.

    collaborator INDUSTRY

  • University of Louisville

    lead OTHER

Principal Investigators

  • Rodrigo Cavallazzi, MD · University of Louisville

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-09
Primary Completion
2025-04-30
Completion
2025-04-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05144633 on ClinicalTrials.gov